ERS Genomics appoints John E Milad as Chief Executive Officer

FHS
May 13, 2024
11:00 am

ERS Genomics Limited (‘ERS’), the CRISPR licensing company, today announced the appointment of John E Milad as CEO, with immediate effect. John brings over 25 years of experience as an executive leader, venture capitalist, and investment banker focused on the life sciences and medical technology sectors.

Monell study uncovers dual role of mammalian sweet taste receptor in regulating blood sugar levels

The rich research portfolio of the Monell Chemical Senses Center on sweet taste goes way back: Monell scientists were one of four teams in 2001

May 17, 2024

Personality traits influence physical activity and sedentary behavior

Associations of personality traits with physical activity and sedentary behavior were observed in a study conducted at the Gerontology Research Centre and the Faculty of

October 30, 2024

Insurance companies are forcing psychiatrists like me to stop accepting their coverage

“I’m sorry, but I’m unable to take on new patients at this time.” I’ve said that line hundreds of times in the 15 years since

January 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.